Dana Investment Advisors Inc. Sells 6,037 Shares of Stryker Corporation $SYK

Dana Investment Advisors Inc. trimmed its holdings in Stryker Corporation (NYSE:SYK) by 22.5% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 20,802 shares of the medical technology company’s stock after selling 6,037 shares during the quarter. Dana Investment Advisors Inc.’s holdings in Stryker were worth $7,311,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Qsemble Capital Management LP boosted its position in shares of Stryker by 758.1% during the 4th quarter. Qsemble Capital Management LP now owns 22,679 shares of the medical technology company’s stock valued at $7,971,000 after acquiring an additional 20,036 shares during the last quarter. Financial Security Advisor Inc. bought a new position in shares of Stryker during the 4th quarter valued at approximately $900,000. Novare Capital Management LLC boosted its position in shares of Stryker by 8.8% during the 4th quarter. Novare Capital Management LLC now owns 38,571 shares of the medical technology company’s stock valued at $13,557,000 after acquiring an additional 3,134 shares during the last quarter. AlphaCore Capital LLC boosted its position in shares of Stryker by 146.4% during the 4th quarter. AlphaCore Capital LLC now owns 3,247 shares of the medical technology company’s stock valued at $1,141,000 after acquiring an additional 1,929 shares during the last quarter. Finally, DNB Asset Management AS boosted its position in shares of Stryker by 3.3% during the 4th quarter. DNB Asset Management AS now owns 69,674 shares of the medical technology company’s stock valued at $24,488,000 after acquiring an additional 2,217 shares during the last quarter. 77.09% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In related news, VP M Kathryn Fink sold 3,500 shares of the firm’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $283.45, for a total transaction of $992,075.00. Following the sale, the vice president owned 177 shares of the company’s stock, valued at $50,170.65. This trade represents a 95.19% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 4.60% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of research analysts have recently commented on SYK shares. Wall Street Zen downgraded Stryker from a “buy” rating to a “hold” rating in a research report on Saturday. TD Cowen lowered Stryker from a “buy” rating to a “hold” rating and set a $387.00 price target on the stock. in a report on Monday, January 26th. Weiss Ratings lowered Stryker from a “hold (c+)” rating to a “hold (c)” rating in a research note on Monday, May 4th. Citigroup reduced their target price on Stryker from $420.00 to $385.00 and set a “buy” rating on the stock in a research note on Tuesday, April 7th. Finally, Leerink Partners started coverage on Stryker in a research note on Monday, April 13th. They issued an “outperform” rating and a $410.00 target price on the stock. Sixteen investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $395.48.

Stryker Stock Performance

Shares of Stryker stock opened at $306.74 on Friday. The firm has a market cap of $117.59 billion, a P/E ratio of 35.50, a P/E/G ratio of 1.93 and a beta of 0.80. The company has a current ratio of 2.11, a quick ratio of 1.25 and a debt-to-equity ratio of 0.62. Stryker Corporation has a 12 month low of $281.00 and a 12 month high of $404.87. The stock’s fifty day moving average price is $329.68 and its 200-day moving average price is $351.73.

Stryker (NYSE:SYK) last announced its quarterly earnings results on Thursday, April 30th. The medical technology company reported $2.60 EPS for the quarter, missing the consensus estimate of $2.98 by ($0.38). The firm had revenue of $6.02 billion for the quarter, compared to analysts’ expectations of $6.34 billion. Stryker had a net margin of 13.20% and a return on equity of 23.42%. The business’s quarterly revenue was up 2.6% on a year-over-year basis. During the same quarter in the prior year, the business posted $2.84 EPS. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. On average, equities research analysts expect that Stryker Corporation will post 14.98 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be given a dividend of $0.88 per share. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $3.52 dividend on an annualized basis and a yield of 1.1%. Stryker’s dividend payout ratio (DPR) is presently 40.74%.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.